Milestone Scientific Inc. (MLSS)

Market Cap	37.40M -34.7%
Revenue (ttm)	8.90M +3.4%
Net Income	-4.57M
EPS	-0.06
Shares Out	88.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	138,220
Open	0.4020
Previous Close	0.4031
Day's Range	0.3953 - 0.4251
52-Week Range	0.2181 - 0.6800
Beta	1.04
Analysts	Buy
Price Target	1.00 (+135.52%)
Earnings Date	May 13, 2026

About MLSS

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides The Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery sys...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 3, 1995
• Employees: 15
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: MLSS
• Website: https://www.milestonescientific.com

Financial Performance

In 2025, Milestone Scientific's revenue was $8.97 million, an increase of 3.99% compared to the previous year's $8.63 million. Losses were -$5.72 million, 21.4% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for MLSS stock is "Buy." The 12-month stock price target is $1.0, which is an increase of 135.52% from the latest price.

Price Target

$1.0

(135.52% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Jul 16, 2026

Data Sources Report a data error